Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE

Liver X receptors (LXRs) α and β are transcriptional regulators of cholesterol homeostasis and potential targets for the development of antiatherosclerosis drugs. However, the specific roles of individual LXR isotypes in atherosclerosis and the pharmacological effects of synthetic agonists remain un...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bradley, Michelle N., Hong, Cynthia, Chen, Mingyi, Joseph, Sean B., Wilpitz, Damien C., Wang, Xuping, Lusis, Aldons J., Collins, Allan, Hseuh, Willa A., Collins, Jon L., Tangirala, Rajendra K., Tontonoz, Peter
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2007
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1924496/
https://ncbi.nlm.nih.gov/pubmed/17657314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI31909
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars